129 related articles for article (PubMed ID: 8142661)
21. [The role of human recombinant erythropoietin in oncologic surgery].
Mercuriali F
Tumori; 1997; 83(4 Suppl 2):S16-9. PubMed ID: 9487379
[TBL] [Abstract][Full Text] [Related]
22. Allogeneic bone marrow transplantation with matched unrelated donors for patients with hematologic malignancies using a preparative regimen of high-dose cyclophosphamide and fractionated total body irradiation.
Geller RB; Devine SM; O'Toole K; Persons L; Keller J; Mauer D; Holland HK; Dix SP; Piotti M; Redei I; Connaghan G; Heffner LT; Hillyer CD; Waller EK; Winton EF; Wingard JR
Bone Marrow Transplant; 1997 Aug; 20(3):219-25. PubMed ID: 9257890
[TBL] [Abstract][Full Text] [Related]
23. Recombinant human erythropoietin (rhEPO) administration to marrow donors. Bone Marrow Transplantation (BMT) Team.
Akiyama H; Tanikawa S; Takamoto S; Sakamaki H; Sasaki T; Onozawa Y
Int J Hematol; 1995 Oct; 62(3):145-9. PubMed ID: 8589358
[TBL] [Abstract][Full Text] [Related]
24. Recombinant human erythropoietin for late-onset anemia after allogeneic bone marrow transplantation.
Fujimori Y; Kanamaru A; Saheki K; Mori A; Takatsuka H; Wada H; Okada M; Tamura S; Okamoto T; Takemoto Y; Kakishita E; Nagai K
Int J Hematol; 1998 Feb; 67(2):131-6. PubMed ID: 9631579
[TBL] [Abstract][Full Text] [Related]
25. Prospective randomised double-blind trial of the in vivo use of recombinant human erythropoietin in bone marrow transplantation from HLA-identical sibling donors. The Australian Bone Marrow Transplant Study Group.
Biggs JC; Atkinson KA; Booker V; Concannon A; Dart GW; Dodds A; Downs K; Szer J; Turner J; Worthington R
Bone Marrow Transplant; 1995 Jan; 15(1):129-34. PubMed ID: 7742745
[TBL] [Abstract][Full Text] [Related]
26. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
[TBL] [Abstract][Full Text] [Related]
27. RBC transfusion requirements after allogeneic marrow transplantation: impact of the before-transplant Hb level on transfusion and early survival.
Xenocostas A; Yee A; Wong CJ; Sutton DM; Lipton JH; Kiss TL; Messner HA
Transfusion; 2003 Mar; 43(3):373-82. PubMed ID: 12675724
[TBL] [Abstract][Full Text] [Related]
28. Clinical use of hematopoietic growth factors in allogeneic bone marrow transplantation.
Lazarus HM; Rowe JM
Blood Rev; 1994 Sep; 8(3):169-78. PubMed ID: 7529606
[TBL] [Abstract][Full Text] [Related]
29. Insulin-like growth factor system components in relation to erythropoietin therapy and bone metabolism in dialyzed patients and kidney transplant recipients.
Małyszko J; Wołczyński S; Zbroch E; Brzósko S; Małyszko J; Myśliwiec M
Nephron; 2002 Mar; 90(3):282-9. PubMed ID: 11867949
[TBL] [Abstract][Full Text] [Related]
30. Donor/recipient mixed chimerism does not predict graft failure in children with beta-thalassemia given an allogeneic cord blood transplant from an HLA-identical sibling.
Lisini D; Zecca M; Giorgiani G; Montagna D; Cristantielli R; Labirio M; Grignani P; Previderè C; Di Cesare-Merlone A; Amendola G; Bergami E; Mastronuzzi A; Maccario R; Locatelli F
Haematologica; 2008 Dec; 93(12):1859-67. PubMed ID: 18945748
[TBL] [Abstract][Full Text] [Related]
31. Serum erythropoietin changes in autologous and allogeneic bone marrow transplant patients.
Ireland RM; Atkinson K; Concannon A; Dodds A; Downs K; Biggs JC
Br J Haematol; 1990 Sep; 76(1):128-34. PubMed ID: 2223632
[TBL] [Abstract][Full Text] [Related]
32. Effect of recombinant human erythropoietin after allogenic bone marrow transplantation.
Link H; Brune T; Hübner G; Diedrich H; Freund M; Stoll M; Peest D; Ebell W; Bettoni C; Oster W
Ann Hematol; 1993 Oct; 67(4):169-73. PubMed ID: 8218537
[TBL] [Abstract][Full Text] [Related]
33. A randomized study of erythropoietin and granulocyte colony-stimulating factor (G-CSF) versus placebo and G-CSF for patients with Hodgkin's and non-Hodgkin's lymphoma undergoing autologous bone marrow transplantation.
Chao NJ; Schriber JR; Long GD; Negrin RS; Catolico M; Brown BW; Miller LL; Blume KG
Blood; 1994 May; 83(10):2823-8. PubMed ID: 7514046
[TBL] [Abstract][Full Text] [Related]
34. Use of recombinant human erythropoietin to assist autologous blood donation by anemic rheumatoid arthritis patients undergoing major orthopedic surgery.
Mercuriali F; Gualtieri G; Sinigaglia L; Inghilleri G; Biffi E; Vinci A; Colotti MT; Barosi G; Lambertengh Deliliers G
Transfusion; 1994 Jun; 34(6):501-6. PubMed ID: 8023392
[TBL] [Abstract][Full Text] [Related]
35. Treatment of acute postoperative anemia with recombinant human erythropoietin.
Levine EA; Rosen AL; Sehgal LR; Gould SA; Egrie JC; Sehgal HL; Moss GS
J Trauma; 1989 Aug; 29(8):1134-8; discussion 1138-9. PubMed ID: 2760953
[TBL] [Abstract][Full Text] [Related]
36. Donor-derived red blood cell antibodies and immune hemolysis after allogeneic bone marrow transplantation.
Hows J; Beddow K; Gordon-Smith E; Branch DR; Spruce W; Sniecinski I; Krance RA; Petz LD
Blood; 1986 Jan; 67(1):177-81. PubMed ID: 3079641
[TBL] [Abstract][Full Text] [Related]
37. Impact of stem cell source on allogeneic stem cell transplantation outcome in hematological malignancies.
Stamatović D; Balint B; Tukić L; Elez M; Tarabar O; Todorović M; Ostojić G; Tatomirovic Z; Ljubenov M; Marjanović S; Malesević M
Vojnosanit Pregl; 2011 Dec; 68(12):1026-32. PubMed ID: 22352263
[TBL] [Abstract][Full Text] [Related]
38. Effect of subcutaneously administered human recombinant erythropoietin on erythropoiesis in patients with myelodysplasia.
van Kamp H; Prinsze-Postema TC; Kluin PM; den Ottolander GJ; Beverstock GC; Willemze R; Fibbe WE
Br J Haematol; 1991 Aug; 78(4):488-93. PubMed ID: 1911340
[TBL] [Abstract][Full Text] [Related]
39. Hematopoietic growth factors for graft failure after bone marrow transplantation: a randomized trial of granulocyte-macrophage colony-stimulating factor (GM-CSF) versus sequential GM-CSF plus granulocyte-CSF.
Weisdorf DJ; Verfaillie CM; Davies SM; Filipovich AH; Wagner JE; Miller JS; Burroughs J; Ramsay NK; Kersey JH; McGlave PB
Blood; 1995 Jun; 85(12):3452-6. PubMed ID: 7540062
[TBL] [Abstract][Full Text] [Related]
40. Minimal allogeneic donor exposure with the use of dedicated donors and a sterile connecting device in a newborn undergoing bone marrow transplantation.
Karandish S; DePalma L; Quinones RR; Luban NL
Am J Pediatr Hematol Oncol; 1994 Feb; 16(1):90-3. PubMed ID: 8311179
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
